WT1 dendritic cell vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for WT1 dendritic cell vaccine, covering 2024-05-16 to 2024-05-16. Get the full timeline:
Most recent: Clinical Trial Update: Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma [Phase 1, Phase 2]